GlassScriptPhysician profile
Vivek B Barclay
NPI 1578594586
$4,386.47
in general payments reported to CMS, 2019-2025
17 companies · $262 in 2025
The $262 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $1,756 · 2021: $472 · 2022: $487 · 2023: $488 · 2024: $622 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,272.57 | 2019-2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $420.73 | 2019-2025 | Relistor |
| Horizon Therapeutics Plc | $139.01 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $105.42 | 2019-2021 | |
| Valinor Pharma, LLC | $72.69 | 2024-2025 | Movantik |
| Protega Pharmaceutials INC | $68.56 | 2025 | Roxybond |
| Shionogi INC | $64.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.81 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $35.74 | 2024-2025 | |
| Forte Bio-Pharma LLC | $32.96 | 2022 | |
| Pfizer INC. | $26.41 | 2021 | |
| Redhill Biopharma INC. | $21.08 | 2021 | |
| Abbvie INC. | $20.89 | 2024 | |
| Biotronik Nro, INC. | $18.80 | 2025 | Prospera |
| Grt US Holding, INC. | $15.80 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $15.54 | 2019 | |
| Ge Healthcare | $14.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Barclay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.